ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Systematic Review
Revised

Application of genus Cassia in the treatment of Constipation: A systematic review

[version 2; peer review: 2 approved, 1 approved with reservations]
PUBLISHED 08 Mar 2021
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

Abstract

Purpose:  Role of genus cassia in the treatment of Constipation
Methods: Methodological analysis, systematic review, and meta-analysis of identified studies using RevMan
Result and Discussion: Cassia fistula was partially effected in treating constipation however there is a need for improvement in the protocol of studies to reduce biases. These results were only limited to one species so it cannot be generalized among all species of Cassia.
Conclusion: Cassia fistula is partially effective in reducing the pain and consistency of stool during constipation among children.

Keywords

Cassia, Cassia fistula, Constipation, Pediatric gastroenterology

Revised Amendments from Version 1

Typing mistakes have been corrected.

See the author's detailed response to the review by Farhad Shokraneh
See the author's detailed response to the review by Massimo Bellini
See the author's detailed response to the review by Sara Naqvi

Introduction

Constipation is a clinical disorder attributed to ineffectual colonic impulsion and/or increased resistance to the proliferation of colonic matters1. Approximately 20% of the world population suffers from chronic constipation2. It is one of the most common pediatric problems3. It was found to be the second most stated disorder in the field of pediatric gastroenterology. Treatment costs for children with constipation will be around three times higher than children without constipation in the United States4. African American children, particularly girls, are greatly affected by constipation, which has been associated with poor hygiene conditions5.

Commonly, constipation is treated by Cisapride in children6, other treatments include polyethylene glycol 3350 and lactulose, however polyethylene glycol 3350 has been found to be more effective7. Supplemented and non-supplemented yogurt helps in reducing abdominal pain and to enhance defecation frequency8. It has been observed that different species of Cassia act effective as a laxative such as Cassia fistula, Cassia alata, and Cassia augustifolia911. The genus Cassia is well known in alternative medicine as hepatoprotective12, laxative, and in the treatment of ringworm infection13, skin diseases14 and leprosy15. It has many pharmacological properties including acting as a hypolipidemic agent16, anti-microbial17, anti-fungal18, and anti-cancer agent19. Genus Cassia contains a number of bioactive compounds such as anthraquinone20, tannin21, coumarins22, triterpene, volatile oil23, phenolic glycoside24, flavonoids25 from different parts of the plant. Different species of Cassia possess laxative properties due to various anthraquinone derivative such as aloe-emodin, rhein, chrysophanol and chrysoobtusin. In this review, we systematically assessed the laxative potential of different species of Cassia.

Methods

Literature search strategy

A systematic literature search was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Using the keywords (Senna AND Laxatives AND Clinical trial) (Cassia AND Laxatives AND Clinical trial) (Cassia AND Clinical trial) (Senna AND Clinical trial) and publication range from 01 January 1960 till 31 December 2018 for identification of the records. Table 1 shows the search strategy for PubMed Central. During screening of the records only full-length open access articles were considered. Abstract only or closed access articles were excluded11. Only articles involving children aged between 2–15 were included. All review articles, in-vivo studies and those >10 years from the search date were excluded. A preliminary search of the PubMed, CNKI, Scopus, Web of Science, Google Scholar and PsycINFO databases and digital archive such as PubMed Central, yielded 2207 papers published in English from the last ten years. Duplicate and irrelevant articles were removed (n=2203). One article was further removed during screening due to closed access (n=3). One publication was removed because the article did not meet the eligibility criteria (n=2). A PRISMA Flow Diagram is given in Figure 1.

Table 1. Search strategy.

PubMed Central
(“cassia”[MeSH Terms] OR “cassia”[All Fields])
AND (“clinical trial”[All Fields] OR “clinical trials as
topic”[MeSH Terms] OR “clinical trial”[All Fields]) AND
(“1960/01/01”[PubDate]: “2018/12/31”[PubDate])
((“cassia”[MeSH Terms] OR “cassia”[All Fields]) AND (“laxatives”[All
Fields] OR “laxatives”[MeSH Terms] OR “laxatives”[All Fields]))
AND (“clinical trial”[All Fields] OR “clinical trials as topic”[MeSH
Terms] OR “clinical trial”[All Fields]) AND (“1960/01/01”[PubDate] :
“2018/12/31”[PubDate])
(“Senna”[MeSH Terms] OR “Senna”[All Fields])
AND (“clinical trial”[All Fields] OR “clinical trials as
topic”[MeSH Terms] OR “clinical trial”[All Fields]) AND
(“1960/01/01”[PubDate]: “2018/12/31”[PubDate])
((“senna plant”[MeSH Terms] OR (“senna”[All Fields] AND
“plant”[All Fields]) OR “senna plant”[All Fields] OR “senna”[All
Fields]) AND (“laxatives”[All Fields] OR “laxatives”[MeSH Terms]
OR “laxatives”[All Fields])) AND (“clinical trial”[All Fields] OR “clinical
trials as topic”[MeSH Terms] OR “clinical trial”[All Fields]) AND
(“1960/01/01”[PubDate] : “2018/12/31”[PubDate])
c5eacc24-0622-48c9-936f-60e4444ab6a6_figure1.gif

Figure 1. PRISMA flow diagram.

Literature screening

Identification of articles were performed at level 1 using the search strategy as mentioned in Table 1. Duplicate articles, irrelevant articles such as polyherbal formulation, review articles, or any article other than Cassia or Senna were removed at level 2. Only four4 articles were identified as being relevant. One record was excluded due to not being a full text article. Abstracts were being reviewed for the following inclusion and exclusion criteria at level 4 and one article was removed for not meeting the eligibility criteria i.e. Randomized, clinical trial on Constipation, full-length open access articles, Pediatric Functional Constipation (age range: 2–15 years).

Eligibility criteria

Types of studies. The author has selected studies of randomized open label, prospective, controlled, parallel-group clinical trial for meta-analysis. Baseline characteristics of randomized trials of studies included on pediatric functional constipation are presented in Table 4. Characteristics of the studies included are mentioned in Table 5.

Types of participants. The author included studies involving patients (aged 2–15 years) with Functional constipation. The diagnosis of Functional constipation was according to according to the Rome III criteria26. Inclusion and exclusion criteria were based on Study design, participants, intervention, outcome (SPIO) criteria and indicated in Table 2.

Table 2. Study design; participants; intervention; outcome (SPIO) criteria.

Inclusion CriteriaExclusion Criteria
Study designRandomized, clinical trial on Constipation, full-length
open access articles, Pediatric Functional Constipation
All review articles, irrelevant articles, Exclude
abstract only articles, clinical trial on adults.
ParticipantsChildren (age range: 2–15 years)Adults
InterventionCassia fistula was delivered to Pediatric with Functional
Constipation
OutcomesRole of the Cassia fistula emulsion in Pediatric Functional
Constipation

Types of interventions. Included studies were focused on the role Cassia in the treatment of Functional constipation. Unfortunately, there were only two studies identified.

Types of outcomes. Eligible studies included consisted of the following outcomes: improvement in the episodes of fecal incontinence per week, improvement in the episodes of retentive posturing per week, improvement in the average of severity of pain of defecation (by VAS), improvement in defecation frequency per week, patient’s drug compliance and improvement in the average of consistency of stool defecated (by VAS).

Methodological quality assessment (MQ)

Methodological quality assessment was made on the basis of following criteria. 1) Aims and Hypothesis clearly defined, adequate sample representation, patient care quality, ethical approval protocol, outcomes assessment, validity and reliability of outcome measure, attempt to blind researcher, follow-up, appropriate statistical analysis and missing data reported. Ten item defined evaluation of methodological quality (MQ) is presented in Figure 2. Risk of Bias were assessed using Cochrane collaboration’s tool on the basis of the following criteria such as selection bias, performance bias, attrition bias, reporting bias and miscellaneous. Cochrane Collaboration’s tool for assessing the risk of bias was used and the results are presented in Table 627.

c5eacc24-0622-48c9-936f-60e4444ab6a6_figure2.gif

Figure 2. Methodological quality assessment of the 2 studies included in the meta-analysis (0=No/not reported, 1=Yes).

Data extraction

The following data were extracted according to study characteristics (e.g., first author, year of publication, search dates, and number of included studies), patient characteristics (functional constipated children, aged between 2–15), sample size, study type (e.g., Randomized open label, prospective, controlled, parallel-group clinical trial study), randomization methods (e.g., “systematic randomization and simple randomization”) and outcome measures/variables (e.g., improvement in defecation frequency per week, improvement in the episodes of fecal incontinence per week, improvement in the episodes of retentive posturing per week, improvement in the average of severity of pain of defecation (by VAS), improvement in the average of consistency of stool defecated (by VAS) and patient’s drug compliance). Data extraction was performed by Muhammad Shazad Aslam. Transcripts were analysed, coded and data was extracted using the demo version of qualitative data analysis software Atlas.ti 8.0. Table 3 represent all the data that was extracted. All the meta-data are available as Dataset 1.

Table 3. Data extraction.

CharacteristicsSeyyed Ali MozaffarpurMohammad Reza Esmaeilidooki
Publication Year20122016
Type of StudyRandomized, clinical trialThis randomized open label, prospective, controlled, parallel-
group clinical trial study
AgeAge between 4–13 yearsAged between 2 – 15 years
Randomizationsystematic randomization Simple randomization
Total Sample Size8151
VariablesFrequency of defecation, consistency
of stools, and severity of pain during
defecation, retentive posturing and
fecal incontinence per week
Improvement in defecation frequency per week,
improvement in the episodes of fecal incontinence per
week, improvement in the episodes of retentive posturing
per week, improvement in the average of severity of pain
of defecation (by VAS), improvement in the average of
consistency of stool defecated (by VAS) and patient’s drug
compliance
Length of each contact
with the participant/
caregivers
Clinical efficacy and tolerance were
assessed using weekly sheets, parents
completed every night. They were
given three sheets (included seven
questions in seven columns) to
complete them daily for 3 weeks.
During the study, we had regular phone calls with the
parents to check the probable complications, treatment
(taking the prescribed drugs) and data filling process. If there
were any serious questions or problems, we visited the child.
At the end of 4 weeks of treatment, the children were visited
and the filled out forms were taken and evaluated.
Blinding of ExperimentThe investigators, the children and
their parents were aware of the study
group assignment.
Fortunately, due to the developing socioeconomic conditions
of the people in these regions in recent years, we were able
to keep in touch with all the patients during the study period
by phone call.
DiagnosisRome III criteria of functional
constipation
Rome III criteria of functional constipation
Diagnostic testParaclinics like anorectal manometry,
thyroid function tests, anti-tTG, and
other laboratory tests
thyroid function tests, anti-tTG, and etc. If it remained any
doubt, barium study and anorectal manometry would be
performed

Table 4. Baseline characteristics of randomized trials of studies included in pediatric functional constipation.

Variable in Treatment (T)Mozaffarpur,
2012 (T)
Esmaeilidooki,
2016 (T)
Mozaffarpur,
2012 (C)
Esmaeilidooki,
2016 (C)
Variable in Control (C)
Sample size in Treatment (N)41524057Sample size in Control (N)
Age, months, Mean(±SD)69.4(±24.3)64.6(±25.2)65.9(±19.1)55.2(±31.2)Age, months, Mean(±SD)
Sex, Male, (n) (%)29(70.7%)3323(57.5%)30Sex, Male, (n) (%)
Weight, Kg Mean(±SD)21.7 (±7.2)20.5(±7.2)20.7(±7.8)18.5(±8.9)Weight, Kg(±SD)
Duration of constipation,
months, Mean(±SD)
34.2(±25.9)31.1(±24.6)30.8(±22.8)23.5(±21.8)Duration of constipation,
months, Mean(±SD)
Defecation ≤ 2 per week, n
(%)
32(78%)4130(75%)52Defecation ≤ 2 per week, n
(%)
Incontinence, n (%)31(75.6%)3427(67.5%)37Incontinence, n (%)
History of previous
treatment, n (%)
32 (78%)4328(70%)51History of previous
treatment, n (%)
Retentive posturing, n (%)32(78%)4029(72.5%)37Retentive posturing, n (%)

Table 5. Study characteristics.

Author, yearStudy DesignHypothesisStatistical analysisSoftwareOutcomes
Mozaffarpur, 2012Randomized,
clinical trial
The author
hypothesized
that Cassia fistula
emulsion (CFE)
would be as
effective or better
than Mineral oil
(MO) in treating FC.
The statistical analyses included
the determination of means and
Standard deviation (SDs),
t test, χ2 test, ANOVA repeated
measures and Fisher’s exact
test, with significance accepted
at the 5% level.
SPSS (version
17),
CFE was most effective
than MO in the 3-week
treatment of children
with FC.
Esmaeilidooki,
2016
Randomized,
clinical trial
N/AThe statistical analyses included
the determination of means
and SDs, t test, χ2 test, ANOVA
repeated measures and Fisher’s
exact test, with significance
accepted at the 5% level.
SPSS IBM20
and STATA 11.2
Significant
improvement when
compared with
the control group
however unable to find
substantial evidence
of the role of identified
bioactive compounds
due to limitation as
it requires further
investigation

Table 6. Cochrane Collaboration’s tool for assessing risk of bias.

Study (author,
year)
Selection
bias
Performance
bias
Detection
bias
Attrition
bias
Reporting
bias
Other
bias
Mozaffarpur, 2012UnclearYesYesNoNoUnclear
Esmaeilidooki,
2016
UnclearYesYesNoNoUnclear

Statistical analysis

Meta-analysis was conducted using the Review Manager (RevMan) 5.3 software28. The summary measures were reported as odds ratios (ORs) or as a standard mean difference (SMD) with 95% confidence intervals (CI). The presence of heterogeneity among trials was assessed using the Chi-square test, and the extent of the inconsistency was measured by I2 statistics. Output file from RevMan is available as Underlying data29.

Results and discussion

Both of the selected studies were not blinded during intervention and outcome assessment that will result in performance bias and detection bias respectively. These biases occur where the investigators know about the participant's treatment group. Performance bias can also refer to the fact that participants can change their responses or behaviour if they know which group they are allocated in. Blinding of outcome assessment may decrease the risk of the investigator or participant being aware of the treatment that a patient is receiving. If the participants and the caregivers are aware of the intervention and outcome that may affect the behavior of the participants, these behavioral changes may affect the performance of the treatment. Clinical trials on adults were also excluded, such as a randomized clinical trial of a phytotherapeutic compound containing Pimpinella anisum, Foeniculum vulgare, Sambucus nigra, and Cassia augustifolia for chronic constipation9. Results of both included studies were non-significant when comparing their baseline characteristics of pediatric functional constipation as presented in Table 5. During analysis of study characteristics, it was found that both of studies demonstrated Cassia fistula is helping to treat constipation among the children as shown in Table 3, but there is a risk of bias according to Cochrane Collaboration’s tool (Table 6). Moreover, both studies found were from one country (Iran). During a methodological assessment, many flaws were identified such as inadequate patient care, attempt to blind the researcher and missing data (Figure 2). During meta-analysis, the comparison was made before and after treatment among different variables such as defaecation, fecal incontinence, retentive posturing, the severity of pain, and consistency of stool. All the variable (before and after treatment) were found to be symmetrical when plotted on a funnel plot as shown in Figure 4, Figure 6, Figure 8, Figure 10, Figure 12, and Figure 14 respectively. The overall effect for some variables is statistically insignificant (P=0.11, P=0.49, P=0.24) such as fecal incontinence, retentive posturing, and acceptance, tolerance respectively. High heterogeneity was found in two variables i.e severity of pain (90%) and consistency of stool (77%). All the forest plot of defaecation, fecal incontinence, retentive posturing, severity of pain, consistency of stool and acceptance and tolerance are represented in Figure 3, Figure 5, Figure 7, Figure 9, Figure 11 and Figure 13 respectively.

c5eacc24-0622-48c9-936f-60e4444ab6a6_figure3.gif

Figure 3. Forest plot in defaecation before and after treatment.

c5eacc24-0622-48c9-936f-60e4444ab6a6_figure4.gif

Figure 4. Funnel plot showing overall standardized mean difference in defaecation before and after treatment.

c5eacc24-0622-48c9-936f-60e4444ab6a6_figure5.gif

Figure 5. Forest plot in fecal incontinence before and after treatment.

c5eacc24-0622-48c9-936f-60e4444ab6a6_figure6.gif

Figure 6. Funnel plot showing overall standardized mean difference in fecal incontinence before and after treatment.

c5eacc24-0622-48c9-936f-60e4444ab6a6_figure7.gif

Figure 7. Forest plot in retentive posturing before and after treatment.

c5eacc24-0622-48c9-936f-60e4444ab6a6_figure8.gif

Figure 8. Funnel plot showing overall standardized mean difference in retentive posturing before and after treatment.

c5eacc24-0622-48c9-936f-60e4444ab6a6_figure9.gif

Figure 9. Forest plot in severity of pain before and after treatment.

c5eacc24-0622-48c9-936f-60e4444ab6a6_figure10.gif

Figure 10. Funnel plot showing overall standardized mean difference in severity of pain before and after treatment.

c5eacc24-0622-48c9-936f-60e4444ab6a6_figure11.gif

Figure 11. Forest plot in consistency of stool before and after treatment.

c5eacc24-0622-48c9-936f-60e4444ab6a6_figure12.gif

Figure 12. Funnel plot showing overall standardized mean difference in consistency of stool before and after treatment.

c5eacc24-0622-48c9-936f-60e4444ab6a6_figure13.gif

Figure 13. Forest plot in acceptance and tolerance after treatment.

c5eacc24-0622-48c9-936f-60e4444ab6a6_figure14.gif

Figure 14. Funnel plot showing overall standardized mean difference in acceptance and tolerance after treatment.

Conclusion

After evaluation of results, it was found that Cassia fistula was not completely effective. It was partly effective in reducing the pain and consistency of stool during constipation. However, these results cannot be generalized among all population. A well designed, expert validated protocol is required in the future. There is a need to develop an instrument that will be free from bias. Moreover, the results cannot be generalized among all species of Cassia as the studies available are only for one species. There is a need to isolate identified bioactive compounds from different species of Cassia and evaluate the effect of different factors such as duration of constipation, defecation, incontinence or retentive posturing under clinical trial.

Declarations

Data availability

Underlying data. Open Science Framework: Application of genus Cassia in the treatment of Constipation: A systematic review. https://doi.org/10.17605/OSF.IO/PKR4N29

This project contains the following underlying data:

  • - Cassia Senna for Constipation.rm5 (study RevMan file)

  • - Quotation Manager.xlsx (study characteristics of citations included in this study)

Reporting guidelines

Open Science Framework: PRISMA diagram and flowchart for the study “Application of genus Cassia in the treatment of constipation: A systematic review”. https://doi.org/10.17605/OSF.IO/PKR4N29

Data are available under the terms of the Creative Commons Zero “No rights reserved” data waiver (CC0 1.0 Public domain dedication).

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 05 Mar 2019
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Aslam MS. Application of genus Cassia in the treatment of Constipation: A systematic review [version 2; peer review: 2 approved, 1 approved with reservations]. F1000Research 2021, 8:256 (https://doi.org/10.12688/f1000research.17893.2)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 2
VERSION 2
PUBLISHED 08 Mar 2021
Revised
Views
5
Cite
Reviewer Report 04 Sep 2024
Sara Naqvi, Iqra University, Karachi, Sindh, Pakistan 
Approved
VIEWS 5
This manuscript is an exemplary piece of research that makes a significant contribution to the field. The authors have presented a thorough and well-structured investigation, with clear and concise writing, impeccable methodology, and rigorous analysis. The results are robust and ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Naqvi S. Reviewer Report For: Application of genus Cassia in the treatment of Constipation: A systematic review [version 2; peer review: 2 approved, 1 approved with reservations]. F1000Research 2021, 8:256 (https://doi.org/10.5256/f1000research.55132.r316436)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 05 Sep 2024
    Muhammad Shahzad Aslam, Xiamen University Malaysia, Malaysia
    05 Sep 2024
    Author Response
    Dear,

    thank you for your comments.

    noted with thanks
    Competing Interests: None
COMMENTS ON THIS REPORT
  • Author Response 05 Sep 2024
    Muhammad Shahzad Aslam, Xiamen University Malaysia, Malaysia
    05 Sep 2024
    Author Response
    Dear,

    thank you for your comments.

    noted with thanks
    Competing Interests: None
Views
8
Cite
Reviewer Report 06 May 2021
Massimo Bellini, Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy 
Approved
VIEWS 8
I've no further particular methodological concerns. My main concern is still the same: I’m really puzzled about ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Bellini M. Reviewer Report For: Application of genus Cassia in the treatment of Constipation: A systematic review [version 2; peer review: 2 approved, 1 approved with reservations]. F1000Research 2021, 8:256 (https://doi.org/10.5256/f1000research.55132.r82025)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Version 1
VERSION 1
PUBLISHED 05 Mar 2019
Views
27
Cite
Reviewer Report 28 Jun 2019
Farhad Shokraneh, University of Nottingham, Nottingham, UK 
Approved with Reservations
VIEWS 27
The author investigates the effect of Cassia fistula on three outcomes based on two included studies. It seems a valuable research that could potentially direct the pharmaceutical companies toward a new agent to treat the constipation.
 
Title
... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Shokraneh F. Reviewer Report For: Application of genus Cassia in the treatment of Constipation: A systematic review [version 2; peer review: 2 approved, 1 approved with reservations]. F1000Research 2021, 8:256 (https://doi.org/10.5256/f1000research.19569.r50310)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 08 Mar 2021
    Muhammad Shahzad Aslam, Xiamen University Malaysia, Malaysia
    08 Mar 2021
    Author Response
    WHO defines 'Adolescents' as individuals in the 10-19 years. So title cannot changed
    Competing Interests: No
COMMENTS ON THIS REPORT
  • Author Response 08 Mar 2021
    Muhammad Shahzad Aslam, Xiamen University Malaysia, Malaysia
    08 Mar 2021
    Author Response
    WHO defines 'Adolescents' as individuals in the 10-19 years. So title cannot changed
    Competing Interests: No
Views
21
Cite
Reviewer Report 23 May 2019
Massimo Bellini, Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy 
Approved with Reservations
VIEWS 21
I’m really puzzled about the usefulness of a review which takes into consideration only two papers and altogether only 132 patients. Constipation, as the author himself states, is a very frequent condition, so the conclusions are inevitably flawed by this ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Bellini M. Reviewer Report For: Application of genus Cassia in the treatment of Constipation: A systematic review [version 2; peer review: 2 approved, 1 approved with reservations]. F1000Research 2021, 8:256 (https://doi.org/10.5256/f1000research.19569.r47237)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Reviewer Response 23 May 2019
    Muhammad Shahzad Aslam, Xiamen University Malaysia, sepang, Malaysia
    23 May 2019
    Reviewer Response
    Dear,

    I have read the report. The selected studies were according to the criteria given inside the paper. So, there were only two selected studies for the systematic review. The comments ... Continue reading
  • Author Response 08 Mar 2021
    Muhammad Shahzad Aslam, Xiamen University Malaysia, Malaysia
    08 Mar 2021
    Author Response
    Please see inclusion criteria (Only articles involving children aged between 2–15 were included. Only articles involving children aged between 2–15 were included.)
    Competing Interests: No
COMMENTS ON THIS REPORT
  • Reviewer Response 23 May 2019
    Muhammad Shahzad Aslam, Xiamen University Malaysia, sepang, Malaysia
    23 May 2019
    Reviewer Response
    Dear,

    I have read the report. The selected studies were according to the criteria given inside the paper. So, there were only two selected studies for the systematic review. The comments ... Continue reading
  • Author Response 08 Mar 2021
    Muhammad Shahzad Aslam, Xiamen University Malaysia, Malaysia
    08 Mar 2021
    Author Response
    Please see inclusion criteria (Only articles involving children aged between 2–15 were included. Only articles involving children aged between 2–15 were included.)
    Competing Interests: No

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 05 Mar 2019
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.